Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hESC-RPE Transplantation for Dry AMD
NCT03046407Phase 2Unknown
- Sponsor
- Chinese Academy of Sciences
- Start
- Sep 2017
- Primary completion
- Jan 2019
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of ASP7317 in age-related macular degeneration (AMD), sponsored by Chinese Academy of Sciences. Status: unknown.
02
Drugs
ASP7317
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT03046407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03046407.